NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

BBNX

Beta Bionics Inc

May 09 • 04:00PM ET

13.95

Dollar change -0.96
Percentage change -6.44	%

Healthcare • Medical Devices • USA • NASD

Held by: VTI IWM VXF IWO SCHA VTWO IWN SCHB RSSL VTWG

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-	Insider Own	20.36%	Shs Outstand	43.35M	Perf Week	17.92%
Market Cap	604.87M	Forward P/E	-	EPS next Y	-2.35	Insider Trans	13.26%	Shs Float	34.53M	Perf Month	18.12%
Income	-	PEG	-	EPS next Q	-0.55	Inst Own	48.57%	Short Float	10.25%	Perf Quarter	-40.64%
Sales	-	P/S	-	EPS this Y	71.05%	Inst Trans	14.50%	Short Ratio	7.42	Perf Half Y	-
Book/sh	7.24	P/B	1.93	EPS next Y	5.62%	ROA	-	Short Interest	3.54M	Perf Year	-
Cash/sh	5.34	P/C	2.61	EPS next 5Y	35.03%	ROE	-	52W Range	8.89 - 24.50	Perf YTD	-40.96%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-43.06%	Beta	-
Dividend TTM	-	Quick Ratio	14.93	Sales past 5Y	3522.02%	Gross Margin	-	52W Low	56.92%	ATR (14)	1.28
Dividend Ex-Date	-	Current Ratio	15.88	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	59.45	Volatility	13.44% 9.94%
Employees	291	Debt/Eq	0.02	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.29	Target Price	25.00
Option/Short	No / Yes	LT Debt/Eq	0.02	EPS Q/Q	-50.30%	Payout	-	Rel Volume	1.23	Prev Close	14.91
Sales Surprise	9.23%	EPS Surprise	-95.50%	Sales Q/Q	111.25%	Earnings	May 06 AMC	Avg Volume	477.27K	Price	13.95
SMA20	21.88%	SMA50	5.67%	SMA200	-11.11%	Trades		Volume	586,951	Change	-6.44%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-24-25	Initiated	Stifel	Buy	$25
Feb-24-25	Initiated	Piper Sandler	Overweight	$26
Feb-24-25	Initiated	Leerink Partners	Outperform	$28
Feb-24-25	Initiated	Lake Street	Buy	$30
Feb-24-25	Initiated	BofA Securities	Buy
Feb-20-25	Initiated	Robert W. Baird	Neutral	$20
Feb-20-25	Initiated	Ladenburg Thalmann	Neutral	$20

May-07-25 03:22AM	Beta Bionics Inc (BBNX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com) +26.61%
May-06-25 04:02PM	Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 (GlobeNewswire)
May-01-25 08:00AM	Beta Bionics to Present at the Bank of America Securities Health Care Conference (GlobeNewswire)
Apr-24-25 11:44AM	Beta Bionics: Slowing Down Or Being Conservative? (Seeking Alpha) +5.74%
Apr-19-25 05:30AM	ClearBridge Small Cap Strategy Q1 2025 Commentary (Seeking Alpha)
04:05PM	Loading…
Apr-16-25 04:05PM	Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 (GlobeNewswire)
Apr-09-25 07:30AM	Beta Bionics to Host Investor Event on June 22, 2025 (GlobeNewswire) +21.63%
Mar-28-25 06:00AM	Newly public Beta Bionics reports sales surge; Dexcom hires CCO (MedTech Dive) -7.58%
Mar-27-25 04:45PM	Beta Bionics Announces Board Appointment of Gerard Michel (GlobeNewswire)
Mar-25-25 04:02PM	Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 (GlobeNewswire) -13.60%
Mar-03-25 12:59PM	Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently (Insider Monkey)
Feb-27-25 07:00AM	Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 (GlobeNewswire)
Feb-21-25 09:35AM	Palantir initiated, Roku upgraded: Wall Streets top analyst calls (TipRanks)
Jan-31-25 05:56PM	Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
06:34AM	Beta Bionics raises $204M in IPO (MedTech Dive)
12:55PM	Loading…
Jan-30-25 12:55PM	Beta Bionics raises $204m to kickstart medtech IPO season (Medical Device Network)
Jan-29-25 10:34PM	Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering (GlobeNewswire)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mensinger Mike	Chief Product Officer	Jan 31 '25	Buy	17.00	33,350	566,950	59,019	Feb 03 08:30 PM
Mensinger Mike	Chief Product Officer	Jan 31 '25	Sale	17.00	13	221	25,669	Feb 03 08:30 PM
Wellington Hadley Harbor Aggre	10% Owner	Jan 31 '25	Buy	17.00	1,000,000	17,000,000	3,901,599	Feb 03 04:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BBNX

Beta Bionics Inc

Upgrade your FINVIZ experience